These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2685699)

  • 1. [Immunologic identification of undetectable neuroblastoma cells by current cytohistological studies of bone marrow samples].
    Gussetis ES; Ebener U; Wehner S; Kornhuber B
    Onkologie; 1989 Aug; 12 Suppl 1():9-11. PubMed ID: 2685699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
    Favrot MC; Frappaz D; Maritaz O; Philip I; Fontaniere B; Gentilhomme O; Bailly C; Zucker JM; Gentet JC; Kemshead J
    Br J Cancer; 1986 Oct; 54(4):637-41. PubMed ID: 3535865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of neuroblastoma in frozen sections of bone marrow trephine biopsy specimens.
    Reid MM; Malcolm AJ; McGuckin AG
    J Clin Pathol; 1990 Apr; 43(4):334-6. PubMed ID: 2187907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological detection and definition of minimal residual neuroblastoma disease in bone marrow samples obtained during or after therapy.
    Gussetis ES; Ebener U; Wehner S; Kornhuber B
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1745-53. PubMed ID: 2698803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.
    Rogers DW; Treleaven JG; Kemshead JT; Pritchard J
    J Clin Pathol; 1989 Apr; 42(4):422-6. PubMed ID: 2654192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical examination of bone marrow in disseminated neuroblastoma.
    Carey PJ; Thomas L; Buckle G; Reid MM
    J Clin Pathol; 1990 Jan; 43(1):9-12. PubMed ID: 1690223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.
    Reid MM; Wallis JP; McGuckin AG; Pearson AD; Malcolm AJ
    J Clin Pathol; 1991 Jun; 44(6):483-6. PubMed ID: 2066428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of immunological analysis for the detection of residual neuroblasts in bone marrow].
    Maritaz O; Combaret V; Favrot MC
    Pathol Biol (Paris); 1988 Jan; 36(1):21-4. PubMed ID: 3283668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of neuroblastoma cells in human bone marrow using a combination of monoclonal antibodies.
    Jonak ZL; Kennett RH; Bechtol KB
    Hybridoma; 1982; 1(4):349-68. PubMed ID: 6765321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to ganglioside GQ discriminates between haemopoietic cells and infiltrating neuroblastoma tumour cells in bone marrow.
    Kemshead JT; Walsh F; Pritchard J; Greaves M
    Int J Cancer; 1981; 27(4):447-52. PubMed ID: 7024141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations].
    Frappaz D; Maritaz O; Favrot MC; Philip I; Bernard JL; Bailly C; Gentilhomme O; Gentet JC; Zucker JM; Bouffet E
    Arch Fr Pediatr; 1987 Nov; 44(9):771-8. PubMed ID: 3446068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
    Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
    N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neuroblastoma monoclonal antibodies which do not bind to bone marrow cells.
    Frantz CN; Duerst RE; Ryan DH; Gelsomino NL; Constine LS; Gregory PK
    Prog Clin Biol Res; 1985; 175():485-99. PubMed ID: 3887430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical detection of bone marrow-invasive neuroblastoma cells.
    Nagai J; Kigasawa H; Tomioka K; Koga N; Nishihira H; Nagao T
    Eur J Haematol; 1994 Aug; 53(2):74-7. PubMed ID: 7522190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal disease in bone marrow of neuroblastoma patients by immunofluorescence.
    Berthold F; Schneider A; Schumacher R; Bosslet K
    Pediatr Hematol Oncol; 1989; 6(2):73-83. PubMed ID: 2702075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method of detecting neuroblastoma in human bone marrow by means of two monoclonal antibodies PI 153/3 and KE2.
    Evans AE; Griffin GC; Tartaglione M; Kennett RH
    Hybridoma; 1985; 4(4):289-96. PubMed ID: 3905579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen.
    Gross N; Beck D; Carrel S; Munoz M
    Cancer Res; 1986 Jun; 46(6):2988-94. PubMed ID: 3516388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytologic detection of neuroblasts in the bone marrow].
    Bayle C
    Bull Cancer; 1988; 75(1):75-7. PubMed ID: 3282576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow changes in neuroblastoma.
    Mills AE; Bird AR
    Pediatr Pathol; 1986; 5(2):225-34. PubMed ID: 3763507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
    Saarinen UM; Coccia PF; Gerson SL; Pelley R; Cheung NK
    Cancer Res; 1985 Nov; 45(11 Pt 2):5969-75. PubMed ID: 2414004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.